SEC Form 4 · accession 0001179110-15-011004
ONCOSEC MEDICAL Inc · ONCS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard B Slansky
Officer — Chief Financial Officer
Period of report
Jul 6, 2015
Accepted (ET)
Jul 8, 2015 · 2:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001444307
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| OncoSec Medical Inc.F1 | Jul 6, 2015 | P | 150,000 | $6.12 | A | 150,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Twenty-five percent (25%) of the shares underlying the option award shall vest on the expiration of a ninety (90) day probationary period starting July 6, 2015 and the remaining seventy-five percent (75%) of the shares underlying the award shall vest in thirty-three (33) equal monthly installments thereafter.